About Droplet
Droplet is a company based in Gurugram (India) founded in 2015 by Sundeep Mittal was acquired by Tata 1mg in March 2017. Droplet has raised $226.64 thousand across 1 funding round from investors including Tata 1mg. The company has 7 employees as of April 05, 2024. Droplet operates in a competitive market with competitors including Orphalan, NIMBLE Diagnostics, OneroRx, Nutrasource and Medi-Globe Group, among others.
- Headquarter Gurugram, India
- Employees 7 as on 05 Apr, 2024
- Founders Sundeep Mittal
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lfs Healthcare Private Limited
- Date of Incorporation 24 Nov, 2015
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
$9.49 M (USD)202.15as on Mar 31, 2023
-
Net Profit
$901.53 K (USD)249.1as on Mar 31, 2023
-
EBITDA
$360.71 K (USD)157.37as on Mar 31, 2023
-
Total Equity Funding
$226.64 K (USD)
in 1 rounds
-
Latest Funding Round
$226.64 K (USD), Seed
Jan 04, 2016
- Investors
-
Employee Count
7
as on Apr 05, 2024
-
Acquired by
Tata 1mg
(Mar 10, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Droplet
Droplet has successfully raised a total of $226.64K through 1 strategic funding round. The most recent funding activity was a Seed round of $226.64 thousand completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Droplet
Droplet has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Tata 1mg.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of an online pharmacy with doctor listing and teleconsultation services
|
Locked | Locked | Locked |
Investor details for Droplet
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Droplet
Investment portfolio details for Droplet
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Droplet
Detailed financials for Droplet
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Droplet Comparisons
Peer comparison for Droplet
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Droplet
Droplet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orphalan, NIMBLE Diagnostics, OneroRx, Nutrasource and Medi-Globe Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer and provider of access to innovative treatments to patients with rare diseases
|
|
| Locked | Locked | Locked |
Non-invasive diagnostic devices for cardiovascular stent monitoring are developed.
|
|
| Locked | Locked | Locked |
Telepharmacy services are delivered via an online platform for consultations.
|
|
| Locked | Locked | Locked |
Marketing services are provided for healthcare, nutraceutical, and pharmaceutical sectors.
|
|
| Locked | Locked | Locked |
Medical diagnostic and treatment solutions are developed and marketed.
|
Detailed competitors of Droplet
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Droplet
Complete news archive for Droplet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Droplet
Droplet was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Droplet is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Droplet is a funded company, having raised a total of $226.64K across 1 funding round to date.
As of Apr 05, 2024, the latest employee count at Droplet is 7.
Annual revenue of Droplet is $9.49M as on Mar 31, 2023.
Droplet was founded in 2015 and is headquartered in Gurugram, India. Operations focus on the healthcare sector, where home-based collection of pathology samples is facilitated alongside diagnostic testing services. These offerings enable accessible medical diagnostics for patients, with activities centered in the Indian market. Key personnel include co-founder Sundeep Mittal.
Droplet's top competitors include Orphalan, PharmaReview and NIMBLE Diagnostics.
Droplet has 1 investor. Key investors include Tata 1mg.